These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 5129469)

  • 1. [Clinical study on the action of a beta blocking agent (LB 46) on some manifestations of hyperthyroidism and hypothyroidism].
    Bricaire H; Pandos
    Presse Med (1893); 1971 Nov; 79(51):2301-4. PubMed ID: 5129469
    [No Abstract]   [Full Text] [Related]  

  • 2. [The beta-blocking drugs in hyperthyroidism. I. Effects on the cardiovascular syndrome].
    Ghidini O; Bellotti G; De Gregori ME; Salazzari G; Giardina F
    Minerva Med; 1971 Mar; 62(26):1363-73. PubMed ID: 4396565
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hypothyroidism, hyperthyroidism and therapy with thyroid hormones: effect on the skeletal system].
    Kann P; Jocham A; Beyer J
    Dtsch Med Wochenschr; 1997 Nov; 122(45):1392-7. PubMed ID: 9410717
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparative study of the clinical and metabolic effects of triiodothyropropionic acid and of L-triiodothyronine].
    Cattano G; Busonera G; Benedetti A
    Minerva Med; 1968 Mar; 59(18):977-85. PubMed ID: 5646213
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical study of a new beta-blocking agent: LB 46].
    Warembourg H; Ducloux G
    Lille Med; 1971 Oct; 16():Suppl 4:1203-8. PubMed ID: 4399711
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of patients with hypothyreosis with thyroidin by the method of variable hormonal vacuum].
    Boriak PM
    Vrach Delo; 1969 Aug; 8():27-30. PubMed ID: 5382480
    [No Abstract]   [Full Text] [Related]  

  • 7. [The beta-blocking drugs in hyperthyroidism. 3. Effects on the post-thyroidectomy course and on the thyrotoxic crisis].
    Giardina F; Bellotti G; De Gregori ME; Ghidini O
    Minerva Med; 1971 Mar; 62(26):1383-92. PubMed ID: 5108134
    [No Abstract]   [Full Text] [Related]  

  • 8. Markers of tissue response to thyroid hormones in patients with hyperthyroidism or hypothyroidism.
    Kucharz EJ; Marcisz C; Jonderko G; Jurecka-Tuleja B; Gołab T; Gina AR
    Rom J Intern Med; 1997; 35(1-4):71-5. PubMed ID: 9562655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The rôle of catecholamines in the clinical manifestations of the hyper- and hypothyroidism syndromes].
    Perrault M; Klotz B; Robillard M
    Sem Hop; 1968 Jun; 44(30):2013-25. PubMed ID: 4300528
    [No Abstract]   [Full Text] [Related]  

  • 10. [Isoproterenol and cardiovascular reactivity in angina pectoris].
    Starcich R; Barbaresi F; Bacuzzi E; Pavarani A
    G Clin Med; 1966 Aug; 47(8):701-19. PubMed ID: 5989215
    [No Abstract]   [Full Text] [Related]  

  • 11. [Test of a new beta-blocking agent, LB 46, in the therapy of angina pectoris].
    Yigitbasi O; Nalbantgil I
    Schweiz Rundsch Med Prax; 1970 Aug; 59(34):1218-21. PubMed ID: 4998107
    [No Abstract]   [Full Text] [Related]  

  • 12. Contribution to the clinical evaluation of beta-adrenergic blocking drugs: 1-p-nitrophenyl-2-isopropylaminoethanol (INPEA) as an antagonist of catecholamines in normal persons and in coronary disease patients.
    Piva M; Ongari R
    Arzneimittelforschung; 1968 Feb; 18(2):179-88. PubMed ID: 5695376
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum leptin and ghrelin levels in premenopausal women with stable body mass index during treatment of thyroid dysfunction.
    Braclik M; Marcisz C; Giebel S; Orzeł A
    Thyroid; 2008 May; 18(5):545-50. PubMed ID: 18466078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Review of literature and experimental contribution on KO 592, a drug with beta-adrenolytic activity. I].
    Marmo E; Caputi AP; Saini RK
    Clin Ter; 1972 Jul; 62(1):11-51. PubMed ID: 4403671
    [No Abstract]   [Full Text] [Related]  

  • 15. Administration of triiodothyronine (T3) for the detection of thyroid deficiency in persons on thyroid replacement therapy.
    Hurxthal LM
    Lahey Clin Found Bull; 1968; 17(3):127-36. PubMed ID: 5743587
    [No Abstract]   [Full Text] [Related]  

  • 16. Laboratory tests for evaluating thyroid therapy.
    Kabadi UM
    Am Fam Physician; 1982 Sep; 26(3):183-8. PubMed ID: 6180620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of sympatholytin on the development of the hemodynamic effects of thyroid hormones].
    Ester KM; Kandror VI
    Biull Eksp Biol Med; 1967 Jun; 63(6):30-3. PubMed ID: 5622606
    [No Abstract]   [Full Text] [Related]  

  • 18. [A beta receptor blocking agent in heart therapy].
    Schmidt-Voigt J
    Med Welt; 1966 Jan; 1():23-6. PubMed ID: 5942360
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiovascular manifestations in thyroid disorders.
    Akhtar M; Singh SJ; Krishnamurti S
    Indian Heart J; 1978; 30(4):203-7. PubMed ID: 700757
    [No Abstract]   [Full Text] [Related]  

  • 20. [Influence of beta-adrenergic block on cardiovascular function and on exercise tolerance in angina pectoris].
    Barbaresi F; Bacuzzi E; Manfredi M; Starcich R
    G Clin Med; 1966 Sep; 47(9):849-64. PubMed ID: 5994051
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.